MedPath

Randomized controlled trial of the influence on mucosal regulatory T cells and fecal butyric acid by administration of Clostridium butyricum and resistant starch for pediatric ulcerative colitis

Not Applicable
Conditions
lcerative colitis
Registration Number
JPRN-UMIN000023885
Lead Sponsor
juntendo University
Brief Summary

The study was terminated because it did not lead to case enrollment and the study period ended.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
0
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with refusal for informed consent, and judged inappropriate.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the frequency of relapse in pediatric ulcerative colitis patients by the administration for 12 months.
Secondary Outcome Measures
NameTimeMethod
mucosal regulatory T cells and fecal butyric acid by the administration for more than 1 month
© Copyright 2025. All Rights Reserved by MedPath